Breaking News

Univercells Launches Cell & Gene Therapy CDMO Exothera

Will partner with innovators to unlock their manufacturing potential by capitalizing on best-in-class manufacturing technologies and bioprocessing expertise

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Univercells has launched a contract development and manufacturing organization (CDMO), Exothera, to support cell and gene therapy developers with process development and production of viral vectors. The company has been created to help alleviate the two most critical challenges manufacturers face in bringing these vital therapies to market: a structural lack of capacity and scarcity of bioprocessing expertise.   Exothera is positioned to create bespoke bioproduction support programs for manufact...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters